Ionis Pharmaceuticals, Inc.
Modulators of SMAD7 expression
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting SMAD7 expression, which may be useful for treating, preventing, or ameliorating a disease associated with SMAD7.
Status:
Grant
Type:
Utility
Filling date:
7 Sep 2018
Issue date:
31 Dec 2019